Alembic Pharmaceuticals Cash Flow Annual

BSE: - | NSE: - | ISIN: - | Sector: -
745.10 -1.90 (-0.25%)Updated : 17 Jun 2026
Fiscal Period2026202520242023
Period End DateMar 26Mar 25Mar 24Mar 23
Issuance( Retirement)of Debt Net 140.86738.56-231.23-17.23
Net Changein Cash 112.90-36.7344.7314.40
Cash Taxes Paid 103.7171.4019.8560.70
Net Income/ Starting Line 693.95707.18631.83354.59
Total Cash Dividends Paid -216.22-216.22-157.25-196.56
Changesin Working Capital -360.51-992.74-115.49-118.26
Cashfrom Operating Activities 782.7587.97803.21723.96
Cash Interest Paid 88.1478.5949.3749.70
Cashfrom Financing Activities -163.79443.71-437.87-261.96
Depreciation/ Depletion 318.55278.58272.67275.43
Other Investing Cash Flow Items Total -11.18-4.796.86-4.18
Capital Expenditures -494.88-563.62-327.47-443.41
period Type ----
Non- Cash Items 130.7694.9514.20212.20
Financing Cash Flow Items -88.43-78.63-49.39-48.17
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities -506.06-568.41-320.61-447.59
Foreign Exchange Effects ----0.01
*All figures in crores except per share values
Recommended For You
Trending Stocks
2,991.00+94.00(3.24%)
261.55+8.00(3.16%)
1,469.45+23.35(1.61%)
352.80-2.65 (-0.75%)